Firebrick Pharma Ltd has released a press release.
Trading Halt
Earlier from Firebrick Pharma
- Registration Agreement and Approval of Nasodine in Indonesia
- Appendix 4D & Half-Year Financial Report to 31 December 2025
- December 2025 Quarterly Activity Report & Appendix 4C
- Nasodine Throat Spray Product Launch in Singapore